Skip to main content

The “Company Name” field currently displays the company associated with the drug identification number (DIN) as of today. A fix will be implemented shortly so the fields will show the company name as it was when the report was originally posted. This issue does not impact the data that can be extracted from the website using the Application Programming Interface (API).

Reports for PERINDOPRIL ERBUMINE

Ingredient

PERINDOPRIL ERBUMINE

Shortage reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
COVERSYL PLUS LD	0.625MG 2MG	TABLET	Resolved	2019-04-26	2019-05-03	82497
COVERSYL PLUS LD	0.625MG 2MG	TABLET	Resolved	2018-11-01	2018-11-19	65971
COVERSYL PLUS LD	0.625MG 2MG	TABLET	Resolved	2018-12-17	2019-01-18	69722
COVERSYL PLUS LD	0.625MG 2MG	TABLET	Resolved	2019-02-20	2019-04-08	76385
COVERSYL PLUS LD	0.625MG 2MG	TABLET	Resolved	2022-12-08	2023-06-01	177561
JAMP PERINDOPRIL ERBUMINE	8MG	TABLET	Resolved	2025-06-07	2025-07-15	259901
JAMP PERINDOPRIL ERBUMINE	4MG	TABLET	Resolved	2025-06-07	2025-09-22	259904
JAMP PERINDOPRIL ERBUMINE	4MG	TABLET	Resolved	2025-06-07	2025-07-15	259895
M-PERINDOPRIL ERBUMINE	8MG	TABLET	Resolved	2025-05-02	2025-07-21	256505
M-PERINDOPRIL ERBUMINE	8MG	TABLET	Resolved	2024-04-18	2024-05-02	225542

Previous
1
…
5
6
7
8
9
…
12
Next

Showing 61 to 70 of 113

Discontinuation reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports

1

Showing 1 to 0 of 0